市場調査レポート
商品コード
1467852
電子データキャプチャシステム市場レポート:展開モード、コンポーネント、開発フェーズ、エンドユーザー、地域別、2024~2032年Electronic Data Capture Systems Market Report by Delivery Mode, Component, Development Phase, End User, and Region 2024-2032 |
|||||||
カスタマイズ可能
|
電子データキャプチャシステム市場レポート:展開モード、コンポーネント、開発フェーズ、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
|
世界の電子データキャプチャシステム市場規模は、2023年に13億米ドルに達しました。今後、IMARC Groupは、2024~2032年の成長率(CAGR)は10.21%で、2032年には31億米ドルに達すると予測しています。臨床試験の急速なデジタル化、クラウドベースのシステム採用の増加、モバイルEDCの採用は、市場を牽引する重要な要因の一つです。
電子データキャプチャ(EDC)システムは、臨床試験データを電子形式で収集・管理するために設計されたソフトウェアツールを指します。EDCシステムは、患者の属性、病歴、有害事象、試験結果、臨床転帰評価、電子インフォームドコンセント(eConsent)、試験実施施設情報など、さまざまなデータを収集します。EDCシステムは、規制当局、治験依頼者、開発業務受託機関(CRO)、治験参加者、データ管理者によって広く使用されています。EDCシステムは、データキャプチャの合理化、データの質の向上、人為的ミスの最小化、機密情報の保護、データ損失や重複のリスクの低減に役立ちます。EDCシステムはまた、臨床試験の効率を高め、リアルタイムのモニタリング機能を提供し、意思決定を支援し、データの正確性、信頼性、一貫性を確保します。
世界中で臨床試験が急速にデジタル化されていることが、市場成長を後押しする主要要因の1つです。EDCシステムは、データキャプチャ、保存、モニタリング、分析など、さまざまな臨床試験業務の自動化に広く利用されており、その結果、プロセスの迅速化、透明性の向上、エラーの防止、全体的な効率化が実現されています。これに加えて、糖尿病、高血圧、アルツハイマー病、多発性硬化症、心血管疾患(CVDs)などの慢性疾患の有病率の増加による新たな治療法や治療に対する需要の高まりも、成長を促進する要因として作用しています。さらに、コスト効率が高く、ユーザーフレンドリーで拡大性があり、安全性が高く、データにリアルタイムでアクセスできるクラウドベースのシステムの採用が増加していることも、市場成長に弾みをつけています。さらに、スマートフォンやタブレットを利用したモバイルEDCの導入は、患者のデータキャプチャに便利で費用対効果の高い方法であるため、エンゲージメントを向上させ、コンプライアンスを高め、エラーのリスクを低減することができ、市場成長に好影響を与えています。これとは別に、データ分析を改善し、迅速な意思決定を可能にし、パターン、動向、異常を特定するための機械学習(ML)と人工知能(AI)の統合が、市場成長にプラスの影響を与えています。さらに、臨床試験データの安全性と完全性に関する厳格な政府規制の実施が、当局へのコンプライアンス強化を支援するEDCなどの高度なデータ管理・報告システムの需要を促進しています。その他の要因としては、個別化医薬品の需要増加、広範な研究開発活動、患者中心の臨床試験への注目の高まりなどが挙げられ、市場成長の原動力になると予想されます。
The global electronic data capture (EDC) systems market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 10.21% during 2024-2032. The rapid digitalization of clinical trials, the rising adoption of the cloud-based system, and the introduction of mobile-EDC represent some of the key factors driving the market.
Electronic data capture (EDC) systems refer to software tools designed to collect and manage clinical trial data in electronic format. They capture a wide variety of data, including patient demographics, medical history, adverse events, laboratory results, clinical outcome assessments, electronic informed consent (eConsent), and study site information. EDC systems are widely used by regulatory agencies, clinical trial sponsors, contract research organizations (CROs), trial participants, and data managers. They help streamline data collection, improve data quality, minimize human errors, protect sensitive information, and reduce the risk of data loss and duplications. EDC systems also enhance the efficiency of the clinical trial, provide real-time monitoring capabilities, assist in decision-making, and ensure data accuracy, reliability, and consistency.
The rapid digitalization of clinical trials across the globe is one of the primary factors propelling the market growth. EDC systems are widely used to automate various clinical trial operations, such as data collection, storage, monitoring, and analysis, which, in turn, accelerate the process, provide transparency, prevent errors, and improve overall efficiency. In addition to this, the growing demand for new treatments and therapeutics due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, Alzheimer's disease, multiple sclerosis, and cardiovascular diseases (CVDs), are acting as another growth-inducing factor. Furthermore, the rising adoption of the cloud-based system, which is cost-effective, user-friendly, scalable, highly secure, and offers real-time access to data, is providing an impetus to the market growth. Additionally, the introduction of mobile-EDC, which utilize smartphones or tablets as a convenient and cost-effective way to collect patients' data, thus improving engagement, increasing compliance, and reducing the risk of errors, is favoring the market growth. Apart from this, the integration of machine learning (ML) and artificial intelligence (AI) to improve data analysis, enable faster decision-making, and identify patterns, trends, and anomalies is positively influencing the market growth. Moreover, the implementation of stringent government regulations regarding the safety and integrity of clinical trial data is facilitating the demand for advanced data management and reporting systems, such as EDC, which aids in ensuring greater compliance with the authorities. Other factors, including increasing demand for personalized medicines, extensive research and development (R&D) activities, and the growing focus on patient-centric clinical trials, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global electronic data capture (EDC) systems market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on delivery mode, component, development phase, and end user.
On-premise
Web & Cloud-based
The report has provided a detailed breakup and analysis of the electronic data capture (EDC) systems market based on the delivery mode. This includes on-premise and web & cloud-based. According to the report, web & cloud-based represented the largest segment.
Software
Services
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the component has also been provided in the report. This includes software and services. According to the report, services accounted for the largest market share.
Phase I
Phase II
Phase III
Phase IV
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the development phase has also been provided in the report. This includes phase I, phase II, phase III, and phase IV. According to the report, phase III accounted for the largest market share.
Hospitals/Healthcare Providers
CROs
Pharmaceutical and Biotechnology Firms
Medical Device Firms
Others
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the end user has also been provided in the report. This includes hospitals/healthcare providers, CROs, pharmaceutical and biotechnology firms, medical device firms, and others. According to the report, CROs accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for electronic data capture (EDC) systems. Some of the factors driving the North America electronic data capture (EDC) systems market included the rising prevalence of chronic diseases, increasing government initiatives, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global electronic data capture (EDC) systems market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anju Software Inc., Calyx, Clario, Datatrak Int, Medidata Solutions Inc., OpenClinica, LLC, Oracle Corporation, Veeva Systems, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.